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Summary
Primary autosomal recessive microcephaly is a clinical
diagnosis of exclusion in an individual with a head cir-
cumference 4 SDs below the expected age-and-sex
mean. There is associated moderate mental retardation,
and neuroimaging shows a small but structurally normal
cerebral cortex. The inheritance pattern in the majority
of cases is considered to be autosomal recessive. Al-
though genetic heterogeneity for this clinical phenotype
had been expected, this has only recently been demon-
strated, with the mapping of two loci for autosomal
recessive primary microcephaly: MCPH1 at 8p and
MCPH2 at 19q. We have studied a large multiaffected
consanguineous pedigree, using a whole-genome search,
and have identified a third locus, MCPH3 at 9q34. The
minimal critical region is ∼12 cM, being defined by the
markers cen-D9S1872-D9S159-tel, with a maximum
two-point LOD score of 3.76 (recombination fraction
0) observed for the marker D9S290.
Autozygosity mapping has been used to identify a third,
novel locus for primary autosomal recessive microceph-
aly, MCPH3, in a consanguineous family of northern
Pakistani origins that has four affected individuals. The
family was originally reported by Heney et al. (1992),
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who described the clinical findings in two Pakistani sis-
ters ages 7 and 8 years (VI:7 and VI:8, respectively; see
fig. 1). Both were microcephalic and of low-normal in-
telligence and were, being educated in a mainstream
school. Since publication of the original description of
the family, a further two individuals with microcephaly
have been ascertained (VI:2 and VI:3; see fig. 1). Both
have nonprogressive mental retardation; VI:2 has mild
mental retardation, whereas VI:3 has moderate mental
retardation but also profound congenital sensorineural
deafness and infrequent tonic/clonic fits. One of the pre-
viously reported individuals, VI:7, assessed as having
low-normal intelligence, is now age 17 years and more
clearly has mild mental retardation, evidenced by in-
creasing difficulties with further education, at school and
at college. The head circumference of all four individuals
was noted to be small at birth and continued to be 6–8
SDs below the expected mean. The other previously re-
ported sister, VI:8, developed acute lymphoblastic leu-
kemia (ALL) and has since died, owing to complications
arising from this condition. The three remaining indi-
viduals with microcephaly are in good health, have nor-
mal growth parameters, and have no other congenital
anomalies, neurological deficits, or dysmorphic features.
Further recent investigations have shown no metabolic
or cytogenetic deficiency, no chromosome breakage
(spontaneous breaks and rearrangements, ionizing-ra-
diation sensitivity, mitomycin C sensitivity, and sister-
chromatid exchange), and no immunoglobulin defi-
ciency. Neuroimaging was not performed, in light of the
good health of the three remaining affected individuals.
No maternal or environmental causes could be found to
explain the finding of microcephaly in the four affected
individuals, and a diagnosis of primary autosomal re-
cessive microcephaly (MIM 251200) was made.
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Figure 1 Revised and extended pedigree (see Heney et al. 1992) with primary autosomal recessive microcephaly, showing genotypes for
eight microsatellite markers at 9q34. The marker order is cen-D9S1811-D9S159-tel. The disease phenotype for affected individuals is micro-
cephaly. The boxed region indicates the homozygous regions in each affected individual.
After linkage to the MCPH1 locus (Jackson et al.
1998) and the MCPH2 locus (Roberts et al. 1999) was
ruled out, a low-resolution whole-genome trawl was per-
formed, with 258 microsatellite DNA markers (Reed et
al. 1994). No homozygous regions were identified that
were common to the affected individuals with micro-
cephaly. Therefore, a higher-resolution screen was per-
formed, with the ABI Linkage Mapping Panel, version
1 (PE Biosystems), decreasing the average marker spac-
ing to 5–10 cM. The only region of homozygosity iden-
tified in all four microcephalic individuals was on chro-
mosome 9, within band q34, with the minimal critical
region, of ∼12 cM, being defined by the markers cen-
D9S1872-D9S159-tel (fig. 1). The MLINK program was
used for two-point linkage analysis (Cottingham et al.
1993; Scha¨ffer et al. 1994). A fully penetrant autosomal
recessive mode of inheritance and a disease-gene fre-
quency of .003 were assumed for primary microcephaly.
Additional polymorphic markers and information re-
garding marker order and relative distances were ob-
tained from the Center for Medical Genetics, Marshfield
Medical research Foundation. Allele frequencies were
calculated by genotyping a panel of 30 unrelated indi-
viduals from the same ethnic group as that of the re-
search family, with a lower limit, .1, set for allele fre-
quencies. A maximum two-point LOD score of 3.76 at
recombination fraction (v) 0 was observed for marker
D9S290 (table 1).
Primary autosomal recessive microcephaly is a clinical
diagnosis of exclusion in an individual with a head cir-
cumference 3 SDs below the expected age-and-sex
mean. There is usually associated mild-to-moderate
mental retardation, but no other neurological or signif-
icant dysmorphic features, with all discernible maternal,
gestational, postnatal, chromosomal, metabolic, or syn-
dromic etiologies being sought and eliminated (Bundey
1997). In the few individuals with primary microcephaly
who have undergone neuroimaging, the cerebral cortex
is small and structurally normal (Bundey 1997). The
inheritance pattern in the majority of cases of primary
microcephaly is considered to be autosomal recessive
(Sujatha and Kumari 1989) with empirical recurrence
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Table 1
Two-Point LOD Scores Calculated on the Basis of Markers
Located at 9q34
MARKER
LOD SCORE AT v =
.00 .01 .05 .10 .20 .30 .40
D9S1811  .07 .82 .95 .67 .31 .08
D9S275 .06 .45 .79 .75 .47 .18 .01
D9S1872 .68 1.07 1.32 1.20 .72 .27 .03
D9S1682 3.30 3.21 2.83 2.36 1.46 .71 .22
D9S1881 1.63 1.57 1.33 1.05 .53 .16 .00
D9S1821 2.18 2.13 1.93 1.67 1.15 .68 .29
D9S290 3.76 3.66 3.26 2.75 1.76 .89 .30
D9S159  .43 .61 .79 .60 .33 .14
a Order is cen-D9S1811-D9S159-9qter.
risks of 1/5 for a white family and 1/4 for a consan-
guineous couple or in the case of a child with symmet-
rical mirencephaly demonstrated by neuroimaging (Tol-
mie et al. 1987; Bundey 1997).
In the family that we are reporting, one of four mi-
crocephalic individuals (i.e., VI:8) had ALL, whereas the
remaining three all are age 118 years and have not de-
veloped any tumors. We therefore suggest that ALL is
most likely to have occurred by chance, rather than to
be due to an underlying predisposition. At present we
have not identified any additional families with primary
autosomal recessive microcephaly linked to this locus.
It would be interesting to know whether the family de-
scribed by Teebi et al. (1987) has linkage to MCPH3,
since it is a consanguineous Arab kindred with auto-
somal recessive nonsyndromal microcephaly, apparently
normal intelligence, and a “peculiar facies” and in whom
one child has also developed a leukemia.
It had been expected that more than one gene could
cause primary microcephaly, because of both clinical
variation between families (Cowie 1960) and the com-
plexity of human brain development. This has recently
been confirmed, with the previous identification of two
loci—MCPH1 at 8p23 (Jackson et al. 1998) and
MCPH2 at 19q13 (Roberts et al. 1999)—and, now, of
a third locus, MCPH3.
Of the genes and expressed sequence tags mapped to
this region of chromosome 9q34 (GeneMap’99; also see
Deloukas et al. 1998), there are two of interest—the
PBX3 gene and the C3G gene. The PBX genes (pre-B
cell–leukemia transcription factors) are a family of hom-
eodomain proteins that have been shown to modulate
the biological activities of the Hox proteins (van Dijk et
al. 1995), including transcriptional control during neu-
rogenesis (Knoepfler and Kamps 1997). C3G (also
known as “guanine nucleotide–releasing factor 2”) has
been suggested to be involved with signal transduction
from tyrosine kinase receptors to the RAS protein in a
number of different tissues (Takai et al. 1994; Tanaka
et al. 1994). As such, it may participate in the signaling
mechanism used by the neurotrophin/TRK pathway to
promote neurone growth and survival. Both the PBX3
gene and the C3G gene are potential candidates for
MCPH3 primary microcephaly, although their role in
brain formation is not fully defined.
The identification of candidate genes for primary mi-
crocephaly is currently hampered by both the lack of
animal models of microcephaly and an incomplete un-
derstanding of the embryological events occurring dur-
ing the development of the mammalian cerebral cortex.
The six-layered structure of the cerebral cortex is mam-
malian specific, and in humans the cerebral cortex has
reached its largest size, thus far, in comparison with body
mass (this process of an increase in the size of the brain
is what anthropologists call “encephalization”; the brain
volume of Australopithecus afarenis was ∼500 cc, that
of Homo habilis was ∼800 cc, and that of H. neander-
thalensis and H. sapiens was/is ∼1,500 cc). It is therefore
likely that the genes in which mutations can cause pri-
mary microcephaly have also been involved in the ev-
olutionary development of the current size and cognitive
abilities of the human brain. Therefore, it is to be hoped
that the future identification of the MCPH3 gene will
provide insights into the evolutionary biology of the ce-
rebral cortex, as well as being of clinical use for families
with primary microcephaly.
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